These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34889942)

  • 1. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.
    Hilligan KL; Namasivayam S; Clancy CS; O'Mard D; Oland SD; Robertson SJ; Baker PJ; Castro E; Garza NL; Lafont BAP; Johnson R; Ronchese F; Mayer-Barber KD; Best SM; Sher A
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34889942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.
    Hilligan KL; Namasivayam S; Clancy CS; O'Mard D; Oland SD; Robertson SJ; Baker PJ; Castro E; Garza NL; Lafont BAP; Johnson R; Ronchese F; Mayer-Barber KD; Best SM; Sher A
    bioRxiv; 2021 Aug; ():. PubMed ID: 34494021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2.
    Sánchez-Morales L; Porras N; García-Seco T; Pérez-Sancho M; Cruz F; Chinchilla B; Barroso-Arévalo S; Diaz-Frutos M; Buendía A; Moreno I; Briones V; Risalde MLÁ; de la Fuente J; Juste R; Garrido J; Balseiro A; Gortázar C; Rodríguez-Bertos A; Domínguez M; Domínguez L
    Vet Res; 2024 May; 55(1):71. PubMed ID: 38822398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG mediated protection of the lung against experimental SARS-CoV-2 infection.
    Hilligan KL; Namasivayam S; Sher A
    Front Immunol; 2023; 14():1232764. PubMed ID: 37744331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells.
    Singh AK; Wang R; Lombardo KA; Praharaj M; Bullen CK; Um P; Gupta M; Srikrishna G; Davis S; Komm O; Illei PB; Ordonez AA; Bahr M; Huang J; Gupta A; Psoter KJ; Creisher PS; Li M; Pekosz A; Klein SL; Jain SK; Bivalacqua TJ; Yegnasubramanian S; Bishai WR
    iScience; 2023 Oct; 26(10):107733. PubMed ID: 37674985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?
    Finotti P
    Cell Stress Chaperones; 2022 Jan; 27(1):37-43. PubMed ID: 34755305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
    Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
    Front Immunol; 2021; 12():812176. PubMed ID: 35095907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation.
    Singh AK; Wang R; Lombardo KA; Praharaj M; Bullen CK; Um P; Davis S; Komm O; Illei PB; Ordonez AA; Bahr M; Huang J; Gupta A; Psoter KJ; Jain SK; Bivalacqua TJ; Yegnasubramanian S; Bishai WR
    bioRxiv; 2022 Mar; ():. PubMed ID: 35313583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence between global BCG vaccination and COVID-19 pandemic.
    Islam MZ; Zahan MK; Al-Bari MAA
    J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific effects of BCG vaccine on viral infections.
    Moorlag SJCFM; Arts RJW; van Crevel R; Netea MG
    Clin Microbiol Infect; 2019 Dec; 25(12):1473-1478. PubMed ID: 31055165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
    Vashishtha VM
    Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis.
    Mata E; Tarancon R; Guerrero C; Moreo E; Moreau F; Uranga S; Gomez AB; Marinova D; Domenech M; Gonzalez-Camacho F; Monzon M; Badiola J; Dominguez-Andres J; Yuste J; Anel A; Peixoto A; Martin C; Aguilo N
    Sci Immunol; 2021 Sep; 6(63):eabc2934. PubMed ID: 34559551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
    Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against
    Bickett TE; McLean J; Creissen E; Izzo L; Hagan C; Izzo AJ; Silva Angulo F; Izzo AA
    Front Immunol; 2020; 11():1202. PubMed ID: 32625209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the BCG vaccine a useful tool against COVID-19?
    Zhelezova G; Mateeva V; Mateev G
    Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.